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ABSTRACT
Background Pneumonia is a leading cause of death
among children under 5 specifically in South Asia and
sub-Saharan Africa. Hypoxaemia is a life-threatening
complication among children under 5 with pneumonia.
Hypoxaemia increases risk of mortality by 4.3 times in
children with pneumonia than those without hypoxaemia.
Prevalence of hypoxaemia varies with geography,
altitude and severity (9%–39% Asia, 3%–10% African
countries). In this protocol paper, we describe research
methods for assessing impact of Lady Health Workers
(LHWs) identifying hypoxaemia in children with signs
of pneumonia during household visits on acceptance of
hospital referral in district Jamshoro, Sindh.
Methods and analysis A cluster randomised controlled
trial using pulse oximetry as intervention for children
with severe pneumonia will be conducted in community
settings. Children aged 0–59 months with signs of severe
pneumonia will be recruited by LHWs during routine
visits in both intervention and control arms after consent.
Severe pneumonia will be defined as fast breathing and/
or chest in-drawing, and, one or more danger sign and/
or hypoxaemia (Sa02 <92%) in PO (intervention) group
and fast breathing and/or chest in-drawing and one or
more danger sign in clinical signs (control) group. Recruits
in both groups will receive a stat dose of oral amoxicillin
and referral to designated tertiary health facility. Analysis
of variance will be used to compare baseline referral
acceptance in both groups with that at end of study.
Ethics and dissemination Ethical approval was granted
by the Ethics Review Committee of the Aga Khan University
(4722-Ped-ERC-17), Karachi. Study results will be
shared with relevant government and non-governmental
organisations, presented at national and international
research conferences and published in international peer-
reviewed scientific journals.
Trial registration number NCT03588377.

INTRODUCTION
Pneumonia accounts for an estimated 18% of
under 5 mortality across the globe.1 Majority
of these pneumonia-specific deaths occur in

Strengths and limitations of this study
►► Our study will directly assess impact of pulse ox-

imetry on family referral acceptance by comparing
family acceptance of hospital referral (verbal acceptance with hospital visit) in ‘pulse oximetry and
clinical signs’ group with ‘clinical signs alone’ group.
►► The study has applicability because it assesses impact with ‘real-life’ limitations (variability in
lady health worker accuracy in identifying severe
pneumonia, availability of oxygen and human resource at referral hospital and, availability of private
transportation).
►► The study design provides means of minimising the
effect of confounding.
►► The study design avoids bias in allocation to exposure groups.
►► Blinding is not possible due to nature of intervention.
►► Some subjects may fail to adhere to protocol and
non-adherence may cause an underestimated measure of association.

15 countries, in which Pakistan ranks fifth.2
Failure to seek early care and delays in hospital
referral are commonly acknowledged determinants of mortality in childhood pneumonia
with a higher proportion reported from rural
settings than urban.3–6 Acceptance rates of
‘facilitated’ hospital referral advice have been
reported low between 8% and 23% for sick
young infants in periurban Karachi.7 8 They
are even lower for non-facilitated referral in
rural settings in children under 5 with severe
pneumonia in rural Matiari district, Sindh.5
The prominent reasons in low-income and
middle-
income countries behind this delay
are inability to recognise seriousness of pneumonia, distance from health facility and lack
of money for private healthcare.9 10
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In 1994, the government of Pakistan introduced the
Lady Health Worker (LHW) programme in rural populations with low physician density to address common
health problems in women and children under 5 through
household visits. To date, a team of over 110 000 LHWs are
working for the programme nationwide with 23 185 LHWs
in Sindh alone.11 Each LHW is responsible for a population of 1000–1500 individuals (catchment of about 100
families). Recruits are preferably local, with a minimum
of 8 years of formal schooling, followed by 15 months of
training to deliver maternal and child healthcare (MCH)
in community settings. During a monthly home visit, the
LHW provides essential MCH services including family
planning needs, nutritional assessments of both mother
and child, management of minor and common illnesses,
improving immunisation coverage and imparting health
education.12
This study recognises the LHW as a powerful conduit for
reaching under 5 children at household level and identifying severe pneumonia in under five at an early stage. It
also recognises the underestimation of hypoxaemia (arterial oxygen saturation, SpO2 of <90%), a major risk factor
for pneumonia mortality at community level and assesses
its prevalence. The reported prevalence of hypoxaemia
in under 5 acutely ill children is 5%–58% in facilities13–16
and 16%–39% in community settings.17 A 4.3-time higher
risk of mortality has been associated with pneumonia with
hypoxaemia than in children with pneumonia without
hypoxaemia.13 Hypoxaemia is also predictive of treatment
failure with amoxicillin in children aged 3–59 months.18
In resource-
poor settings where pulse oximetry is not
feasible, signs and symptoms of severe pneumonia (sleepiness, cyanosis, head nodding/grunting and inability to
move) are used as predictors of hypoxaemia. However,
the validity of clinical signs to predict hypoxaemia varies
and it is often difficult for physicians working in settings,
where objective detection of hypoxaemia is not available,
to decide whether the child coming with severe pneumonia requires administration of oxygen or not.15 19 20
Pulse oximetry16 is a rapid, portable, non-invasive and
accurate method of measuring Sp02 and has therefore
been used in trial and clinical settings to detect hypoxaemia. Appropriate oxygen therapy (based on PO findings rather than clinical signs of severity alone) has been
associated with lower mortality risk.19 Assuming access
to supplemental oxygen, PO could potentially avert up
to 148 000 severe pneumonia-
related deaths if implemented, and, combining PO with IMCI assessment for
pneumonia has been shown to be cost-effective in 15 high
burden countries.21 Emdin et al found first level LHWs
in periurban Karachi could easily perform pulse oximetry on young infants on well and sick visits to a primary
healthcare facility.22
Over the past decade, the possible impact of pulse oximetry in hospital and community settings has been of interest
across the globe. Health survey of 54 countries in 2010,
suggested that 19.2% of the operating theatres around
the globe are not equipped with pulse oximeters.23 Trials
2

assessing utility of pulse oximetry on a health systems level
in Nigeria have shown that health workers reserve PO for
the sickest patients.24 25 This has also been observed in
areas at higher altitudes with higher prevalence of hypoxaemia (highlands of Papua New Guinea).25 26 There is
lack of clarity about how pulse oximetry can be used in
the community where lower hypoxaemia prevalence may
be a lesser incentive for health workers to use PO such as
in interior Sindh settings in Pakistan. Then again, health
workers recruited from within communities may be
better invested and motivated than hospital personnel in
following case management guidelines precluding PO. It
is, therefore, worthwhile to explore and describe contexts
behind a family’s acceptance (or not) of referral advice
whether based on technology and/or clinical examination in rural settings where the highest burden of pneumonia deaths lies.
Feasibility and sustainability audits of oxygen delivery
systems in the Gambia and Egypt have shown that
providing technology alone is ineffective, and should
preclude provision of supplies, education, training and
feedback.27–30 This protocol paper describes a study to
assess the effect of PO monitoring in community settings
on hospital referral acceptance in children under 5 with
severe pneumonia.
METHODS
Study aims and design
The overall aim of the study is to assess if detection of
hypoxaemia, and/or severe pneumonia in children 0–59
months by LHWs during their monthly home visits will
increase hospital referral acceptance among families in
district Jamshoro, Sindh, Pakistan.
Primary objectives are:
1. To assess and compare the impact of ‘pulse oximetry’
used by LHWs at household level on increasing hospital referral acceptance rates in intervention clusters
(district Jamshoro) for children aged 0–59 months
with severe pneumonia with the impact of LHWs using
clinical signs alone in non-intervention clusters of the
same district.
2. To investigate the likely predictors (demographic, clinical) of hospital referral acceptance in both the groups.
Secondary objective is:
3. To compare clinical outcomes (treatment completion, treatment failure, hypoxaemia) of children 0–59
months who accepted referral to those who refused admission and were treated at home.
A community-
based cluster randomised trial will be
conducted in district Jamshoro, among children of ages
0–59 months (figure 1). In intervention areas, all children
with cough, fever or difficulty in breathing (acute respiratory illness) will be assessed for study eligibility (signs
and symptoms of severe pneumonia, or hypoxaemia
alone, or severe pneumonia with hypoxaemia) by LHWs
during their monthly home visit in their catchment area.
In control areas, study eligibility will require detection of
Mir F, et al. BMJ Open 2021;11:e046158. doi:10.1136/bmjopen-2020-046158
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Figure 1 Trial profile. LHW, Lady Health Worker, PO, Pulse
Oximetry.

signs of severe pneumonia alone (online supplemental
appendix 1) during LHW monthly visits. Data will be
collected on demographics, likely predictors and clinical
outcomes using a structured questionnaire.
The primary outcome is hospital referral acceptance in
children under 5 with severe pneumonia and to identify
demographic and clinical predictors of hospital referral
acceptance. The predictors will include distance of child
home to referral facility, socioeconomic status of household, parental education, child age, nutritional status,
respiratory rate, temperature, hypoxaemia and presence
of other illnesses.
Secondary outcomes include duration of oxygen
therapy, treatment failure, duration of hospital stay, vital
and health status of child at day 7th and 14th.
Trial setting
The study will be conducted within the community of
Taluka Kotri in District Jamshoro, Sindh (figure 2). Jamshoro District has a population of 993 142.31 It is predominantly rural, with 33% literacy, and >50% employed
daily wage labourers. A baseline survey conducted as a
part of current study showed the status of overall health
indicators: skilled birth attendance 57%, antenatal care
coverage 75%, postnatal care cover for mother and
newborn within 48 hours 31.5%, vaccination completeness in children 12–23 months 68% and care seeking for
ARI and diarrhoea >80% (internal survey). A total of 27
health facilities function in the district including 1 district
headquarter (DHQ) hospital, 3 taluka headquarter hospitals, 5 rural health centres and 18 basic health units. The
district is divided administratively in 30 union councils.
Kotri is one of the four Talukas of Jamshoro, consists of
44% (437 561) of the population of district.31
Mir F, et al. BMJ Open 2021;11:e046158. doi:10.1136/bmjopen-2020-046158

Figure 2 Map of intervention and control sites Abbreviations
used in Map: Liaqat University of Medical and Health
Sciences Jamshoro (LUMHS). Legend: Lady Health Worker
(LHW). Service Layer Credits: Companies/institutes which
contributed and collaborated to make this basemap publicly
available (Environmental Systems Research Institute (ESRI),
HERE (private company), General Bathymetric Chart of the
Oceans (GEBCO), US Geological Survey (USGS), Food and
Agriculture (FAO), National Park Service (NPS), National
Resources Canada (NRCan), GeoBase, Institut Geographique
National (IGN), Ministry of Economy, Trade and Industry
(METI).

Participants will be the permanent residents of Kotri,
Jamshoro and recruited from their homes during routine
monthly visits by LHWs serving in their catchment areas.
This study is expected to run for 48 months with participant identification and enrolment conducted simultaneously in intervention and control clusters over 21 months
after an initial pilot of 1 month. Each enrolled child will
be revisited at day 7 and 14 for outcome measurement.
Participant
Any child aged 0–59 months having signs and symptoms
of acute respiratory illness (cough, fever, difficulty in
breathing) in intervention clusters will undergo assessment of (1) signs and symptoms of severe pneumonia and
(2) pulse oximetry during monthly LHW home visits. Presence of severe pneumonia with or without hypoxaemia,
or hypoxaemia alone will merit hospital referral (non-
facilitated). Any child aged 0–59 months having signs and
symptoms of acute respiratory illness (cough, fever, difficulty in breathing) in control clusters will undergo assessment of (1) signs and symptoms of severe pneumonia
alone. Presence of severe pneumonia will merit hospital
referral (non-facilitated). Exclusion criteria will include
lack of consent and, non-availability (lost to follow-up,
migration) on days of scheduled follow-up visits (days 7
and 14). Those who accepted referral but did not show
up at hospital will be included in final analysis.
Randomisation and masking
Study clusters were defined as the area covered by an
LHW. Each LHW covers a minimum of 100 households.
3
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A list of LHWs working in Kotri was collected from the
LHW programme, health department government of
Sindh. There are a total of 188 active LHWs in the study
site. A baseline survey was conducted to collect data on
health indicators from the LHW catchments. The clusters were randomly allocated to intervention and control
groups on 1:1 fashion with a computer-generated randomisation sequence that was generated by an independent
expert. Clusters were matched on under 5 population
and distance to referral health facility. No stratification
was used for allocation; clusters were selected to ensure
that the reporting and training centres of intervention
and control LHWs were separate. The investigators and
the national and provincial LHW programme coordinators will be excluded from the allocation process.
Training of LHWs
The LHW programme of Pakistan consists of a community-
based group of first-level health workers with the principal mandate of home-based maternal and child health.
The recruitment process is well defined and selection
criteria include: at least 8 years of education with middle
school pass, local residency, recommendation from the
community and preferably married.32 Once selected, they
receive 15 months of basic training in mid-wifery and
family planning using standardised training manuals and
curriculum, and periodic refresher training courses. Each
of these LHWs is typically responsible for approximately
1000 people, or 150 homes, and often serve as the primary
healthcare contact in these rural communities.32 33
We chose LHWs as study personnel due to their access
to homes on regular monthly basis. We trained intervention and control LHWs in separate groups for all of the
following: (1) classification of ARI (no pneumonia, pneumonia, severe pneumonia) using standard acute respiratory infections training modules (WHO and IMNCI), (2)
identification of danger signs and (3) case management
of pneumonia at home with oral amoxicillin and severe
pneumonia with stat dose of antibiotic before hospital
referral. Intervention LHWs received an additional
training in using a pulse oximeter and obtaining a valid
reading. The principal investigator (PI) led these training
sessions with senior trainers of the LHW programme
(lady health supervisors).
Participant recruitment and study procedures
Intervention delivery
Children aged 0–59 months with cough and/or difficult breathing during regular home visits of LHWs will
be assessed for first, signs and symptoms of severe pneumonia (fast breathing/chest in-drawing and one or more
danger sign (unable to eat/drink, vomiting, convulsion
and lethargy/unconsciousness) and/or stridor)) and
second, hypoxaemia (SpO2 <92%) using a handheld
pulse oximeter (Masimo Rad-5v) to measure blood oxygen
saturation level. LHWs will also do case management of
children with pneumonia and severe pneumonia. A 3-day
course of oral amoxicillin will be given to children with
4

pneumonia at home, whereas children meeting referral
criteria (severe pneumonia alone, hypoxaemia alone
or severe pneumonia and hypoxaemia) after obtaining
informed consent (online supplemental appendix 2),
will be administered a stat dose of oral amoxicillin and
referred to nearest referral hospital (DHQ Kotri).
The study investigators will have provided these pulse
oximeters to the LHW programme in advance and highlighted which ones will receive them. Physicians at the
referral centre serving the intervention clusters will also
receive handheld pulse oximeters. All the LHWs and
staff will be trained on the use, and maintenance of these
pulse oximeters. Children with severe pneumonia with or
without hypoxaemia will be advised to go to hospital for
antibiotics and oxygen, using the PO reading as a tool
to convince parents. Children with hypoxaemia alone,
without signs of severe pneumonia, will be referred to
hospital to rule out cyanotic congenital heart disease.
Name of the predesignated health facility with available oxygen and study physician will be provided to
all the LHWs so that Study Workers (non-LHW study
personnel) can coordinate with study physicians and
ensure the patient has reached and is receiving safe and
recommended care at referral facility. Project staff will
pretest and regularly monitor PO accuracy and quality of
readings.
Hypoxaemia will be defined as an SpO2 <92%. SpO2
measurement will be recorded after 1 min of stable observation. If the SpO2 comes 92% or less, the child will first
be assessed for nasal obstruction with readings repeated
after applying nasal saline drops. If repeat reading shows
hypoxaemia, the child will be referred to nearest designated referral hospital and admitted for oxygen via nasal
or nasopharyngeal route and intravenous antibiotics, as
per recommendations.
Implementation of active control: clinical signs assessment
Children aged 0–59 months with cough and/or difficult
breathing during regular home visit will be assessed by
LHWs for signs and symptoms of severe pneumonia (fast
breathing/chest in-drawing and one or more danger sign
(unable to eat/drink, vomiting, convulsion and lethargy/
unconsciousness) and/or stridor)). A 3-day course of oral
amoxicillin will be given to children with pneumonia at
home, whereas children with severe pneumonia (eligible
for recruitment) will be requested for informed consent
and offered stat dose of oral amoxicillin and referral to
nearest referral hospital.
Procedure at referral facility
Children who accept hospital referral in both intervention and control clusters and reach hospital premises
with LHW referral slip will be assessed by study physician at the referral centre. An SMS notification with
brief details of referred child will have been provided to
trained study personnel (study physician) in advance at
time of referral at both the referral facilities. Children
with severe pneumonia and/or hypoxaemia as per LHWs
Mir F, et al. BMJ Open 2021;11:e046158. doi:10.1136/bmjopen-2020-046158
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who reach referral hospital premises will be examined
and subjected to pulse oximetry again by the study physician at referral facility. If signs and symptoms of severe
pneumonia are present, the child will be admitted for
further appropriate treatment (oxygen therapy via nasal
or nasopharyngeal route and intravenous antibiotics, etc)
and if the symptoms are not severe (absence of danger
sign), the child will be treated in outpatient care as per
the standard of referral facility. All the children admitted
at referral facility will undergo 12 hourly monitoring by
study personnel and filling of CRF and hospital physician form (HPF) at days 1, 7 and 14. Those children who
refused the referral will be visited by study community
health workers after 24 hours to confirm referral refusal
and to fill CRF.
Preliminary meetings will be held with the executive
director health Jamshoro, director general health Sindh,
in-charge LHW programme Sindh and in-charge paediatric units LUMHS to ensure their cooperation through
study duration. Emergency and paediatric unit staff at
the referral facilities along with study personnel (physician/nurse) will be trained on management of severe
pneumonia according to the integrated management of
neonatal and childhood illnesses (IMNCI) guidelines.34
A baseline survey will be conducted at the health facilities to ensure availability of oxygen and necessary intravenous antibiotics. Even though it is ideal to guarantee
sustainable oxygen systems at the two chosen referral
public sector hospitals, this study does not provide
oxygen, and therefore, aims to assess ‘real-life’ situations
in public hospitals and their impact on severe pneumonia outcomes with or without hypoxaemia. LHWs will
be incentivised on basis of their contribution to the study
activities.
Data collection and storage
Data will be collected by LHWs during house visits
(screening form), community health workers (during
follow-
up visits days 1, 7 and 14) and hospital-
based
study personnel (for all who accept referral and reach
hospital premises) on paper forms (online supplemental
appendix 3). Given that it will be a new experience for
LHWs to assess, classify and manage ARI cases and at the
same time record findings on data forms accurately, these
will be supervised closely and frequently, at least for the
first pneumonia season. Well trained study field supervisory officers and LHW supervisors will be required
to perform regular field supervision in their respective
clusters and ensure accurate and logically entered data
forms and make necessary verifications and corrections
at the data collection sites and give feedback to the LHW
to avoid repeating the errors. Raw data brought to the
programme office will be checked once again for accuracy by the technical staff and approved for entry in the
computer. All raw data will be safely kept in the AKU
office, appropriately numbered by cluster, until 7 years
after the study is over.
Mir F, et al. BMJ Open 2021;11:e046158. doi:10.1136/bmjopen-2020-046158

Case history records
These include the study CRF and HPF that will contain
information that documents the child’s eligibility to
participate in the study, the signed consent form and
information from tests and examinations. Wherever
possible copies of supporting documentation for the
information contained in the CRF should be kept with
each patient’s case history record. This supporting documentation may include records of physical examinations,
progress notes, laboratory reports, X-rays, consultations,
correspondence, information and data on the subject’s
condition, during and after the clinical investigation,
diagnoses made, concomitant therapy, etc. All information in the case history records should be attributable
to a specific individual. Since the CRF will not contain
the patient’s name, there will be a unique link between
the ID number on the CRF and the patient’s name. Each
child’s case history record will be evaluated to verify
validity and completeness of the data on the CRF when a
study monitor visits the study site. All corrections to CRF’s
must be made without obscuring the original entry. The
revised entry should be inserted and the person making
the correction should sign and date the correction. Only
authorised study personnel may complete or correct
CRFs.
Data management
Screening data will be collected on paper by LHWs.
CRF and HPF will be collected on electronic forms. To
ensure proper implementation of the intervention, the
field supervisors will make spot checks and will arrange
monthly refresher group sessions of the first-line health
workers in which the problems encountered will be
discussed and resolved. In addition, the data collection
activity will be carried out by teams consisting of LHWs/
CHWs and study staff will be further monitored by field
supervisors who will perform a check on a subset (5%) of
households.
An information system will be set up to keep track
all patients screened and enrolled and a filing system
to keep all study related records—case history records,
study protocol or related documentation and drug
distribution records. The coordinator at the site will be
responsible for the completeness and accuracy of all the
study materials.
Study protocol and related documentation
related documents including the study
All study-
protocol, manuals of operations, all correspondence
sent to or received from the study monitor, materials
used for obtaining informed consent, protocol modifications and records of the institutional review board
(IRB) approval and all communications with the IRB
must be maintained in complete form. These documents will be evaluated to ensure that study documentation is complete and current when a study monitor visits
the study site.
5
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Record retention
Retention of accurate and complete records is essential
to establish the validity and completeness of the study.
All records must be retained for 7 years after the data set
is frozen. Electronic data will be deidentified, unlinked
from any personal identifiers and therefore will protect
individual identity.
Reporting of serious adverse events and treatment failures
Amoxicillin is in widespread use and is not investigational
in any study site. However, since oral amoxicillin is not
routinely recommended for initial treatment of children
who have severe pneumonia, the appropriate case report
forms (CRFs) describing the occurrence of a serious
adverse event, treatment failure or death must be faxed to
the coordinating centre within 72 hours of the site coordinator knowing about the event. Adverse events, treatment
failure and death must be reported to allow appropriate
interpretation of this critical information. If the outcome
of the adverse event is unknown when the site coordinator first notifies the coordinating centre, a follow-up
form must be faxed to the coordinating centre within 10
days of knowing about the event. The PI should send a
copy of the adverse event data to their local IRB as soon
as possible. The coordinating centre will summarise the
adverse event and death information and send a report to
the IRB/ERC of sponsors and to site IRBs. Both the rate
of adverse events and the rate of patient accrual at each
individual site will be monitored to determine if stopping
rules are met. We do not anticipate serious adverse events.
However, in case of one, a DSMB will be requested for
and convened on ad hoc basis for safety review at any time
during the study if there is a concern regarding rates of
adverse events or rates of patient accrual. Adverse events
will be reported by the study physician to the PI and clinically managed by the study physician in conjunction with
other physicians at the institution. Any related and unexpected life-threatening adverse event including death will
be reported to the IRB within two business days as per IRB
protocol and any related, unexpected and serious adverse
event will be reported to the IRB within 10 business days
as per IRB protocol.
Compliance with and deviations from the study protocol
The site coordinator must agree with and sign the
protocol and confirm in writing that he or she has read,
understands and will work according to the protocol and
Good Clinical Practice. The site coordinator is responsible for making sure that the protocol is strictly followed
and should not make any changes to the study unless
necessary to eliminate an apparent immediate hazard or
damage to a trial subject. Any deviations from the study
protocol including but not limited to inappropriate
enrolment of a study subject, administration of the wrong
study treatment, missed doses of study treatment, missed
observation points, incorrect administration of concomitant medications, etc should be reported to the coordinating centre and each site’s IRB. The report should
6

include a plan to rectify any problems at the site that may
have caused the protocol deviation.
Sample size
Defining a cluster as (the catchment area of) one LHW,
and assuming a power of 90% in detecting 50% increase
in referral acceptance from a 10% baseline to 15% among
children aged 0–59 months with severe pneumonia
(pneumonia prevalence at 2-week recall (MICS Sindh):
7.5% (18% of which is assumed severe pneumonia) with
ICC 0.001736. We need to capture a total of 4160 children
with severe pneumonia in both intervention and control
groups.
Data analysis
The primary analysis for each outcome will perform on
an ‘intention-to-treat’ basis, that is, all children included
in the analysis who were enrolled in the study according
to the group to which they were allocated. All analyses
will account for the cluster randomised design to ensure
correct type I error rates and CIs.35 Baseline characteristics will be compared by analysing differences in means
and proportions among the study arms. Categorical
outcomes will be compared using χ2 test and continuous
outcomes using Student’s t-test. For analysis of predictors of referral acceptance, generalised linear model will
be used with logit link function. The univariate analysis
will be conducted to explore the independent effect of
each predictor on outcome. The variables significant at a
liberal p <0.20 will be included in multivariate model for
adjustment. The results will be reported as relative risk
with 95% CI. Type 1 error will be set at 5% level. All analysis will be done using STATA V.15.
Patient and public involvement
Patients or the public will not be involved in the design or
conduct of the study. Results will be disseminated to the
community.
Study status
Recruitment began in August 2019 and field activities and
data collection are in process. As of 16 October 2020, a
total of 235 cases and 184 controls have been enrolled.
Extension of study duration is in discussion to achieve
sample size.
DISCUSSION
Hypoxaemia, a frequent complication of severe pneumonia, is a major risk factor for death in children under
5. Theoretically, detection of hypoxaemia at community
level among severe pneumonia cases by the use of pulse
oximeter would give awareness to the caregivers about
severity of illness and reduce delay in hospital referral.
Delayed care-seeking is a recognised risk factor in pneumonia mortality in community settings.36 Unfortunately,
information on prevalence of hypoxaemia, effectiveness
of its detection in influencing parents to seek hospital
care (gold standard for severe pneumonia) and impact
Mir F, et al. BMJ Open 2021;11:e046158. doi:10.1136/bmjopen-2020-046158
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of appropriate care at hospital in settings like Pakistan is
lacking. Thus, the findings of this study will build evidence
for utility of providing front-line workers like LHWs with a
tool to detect hypoxaemia if signs and symptoms of pneumonia are present. Interestingly various groups across
the world are now espousing pulse oximetry with other
strengths like detection of congenital heart disease37 38
and newborn sepsis.39
Limitations
Some union councils with poor LHW coverage were not
included in this study. This was a compromise on generalisability in favour of feasibility. It may have led to exclusion of children whose referral patterns were important to
gauge. We also did not offer facilitated referral in either
arm. This may have affected referral acceptance in both
groups, however, will allow assessment of real-life impact
of transportation barriers.
Though we kept hospital referral (as recommended by
WHO) for severe pneumonia as our standard of care, it
was beyond the scope of this study to ensure that referral
centres had sustainable oxygen systems/capacity for non-
invasive ventilation in children with severe pneumonia,
or readily available cardiac evaluation resources for children with hypoxaemia alone. Duke et al showed improved
case fatality rates by providing oxygen concentrators and
pulse oximeters at five hospitals in PNG along with protocols for use.35 Lack of quality care at referral hospitals in
developing countries is a recognised barrier to healthcare
seeking behaviour.40 41
If our study reveals pulse oximetry has influenced
health-
seeking behaviour significantly, we will need to
follow with a more systematic evaluation of pneumonia
care at rural hospitals which vary in quality of care. We
will also need to correlate recovery rates in those who
accepted hospital referral versus those who stayed home
on oral amoxicillin. Evidence to support home care for
severe pneumonia is poor.42
The COVID-19 pandemic has adversely affected
recruitment in the study with disruption of field activities
for many months in 2020. We anticipate prolongation of
study duration in order to achieve sample size.
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